Jeroen Albert Adrianus van de Pol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeroen Albert Adrianus van de Pol has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Geert Smits
GP Organization PoZoB, Veldhoven, the Netherlands
3 shared publicationsPepijn H. van der Voort
Netherlands Heart Network, Eindhoven, The Netherlands
3 shared publicationsDennis van Veghel
Netherlands Heart Network, Eindhoven, The Netherlands
2 shared publications- Frederique Jantine Hafkamp2 shared publications
- Hareld Marijn Clemens Kemps
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands
2 shared publications Henricus-Paul Cremers
Netherlands Heart Network, Eindhoven, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e89187
Real-World Impact of Remote Patient Management on Care Consumption and Care Time in Heart Failure: Retrospective Cohort Study
Background: Remote patient management (RPM) is a strategy to track daily health data in patients with heart failure (HF) to enable early detection and treatment of decompensation to prevent hospital readmissions. The implementation of RPM alters standard care and redistributes provider responsibilities. Although randomized controlled trials demonstrate positive clinical outcomes, the impact of implementing RPM on patients’ health care usage, as well as the care time and workload of health care providers in a real-world setting, remains unclear. Objective: The objective of this retrospective study is to explore the effects of implementing RPM for HF on patients’ cardiac care consumption and caregiver workload within a regional care network through the use of real-world data. Methods: Two hospitals in the same regional care network with aligned care pathways for usual care (UC) were compared: one with RPM (hospital 1) and one without (hospital 2). Between June 2021 and July 2022, patients with HF were included from a clinical registry with a 1-year follow-up. Cardiac health care consumption was quantified by the number and duration of consultations (in-person, phone, and RPM) with nurse practitioners specialized in HF care and cardiologists. HF-related readmissions were also collected. Three groups were analyzed: hospital 1 RPM, hospital 1 UC, and hospital 2 UC. Results: A total of 131 patients were included (hospital 1 RPM: 34, hospital 1 UC: 64, hospital 2 UC: 33). Consultation frequency and duration were significantly higher in the hospital 1 RPM cohort compared to the hospital 1 UC and the hospital 2 UC cohorts (frequency: mean 18.5, SD 9.3 vs mean 9.3, SD 6.0 and mean 11.6, SD 6.3; P <.001; duration: mean 233.2, SD 95.2 min vs mean 121.2, SD 47.9 min and mean 113.0, SD 66.0 min; P <.001), mainly due to increased number of consultations of nurse practitioners specialized in HF care (hospital 1 RPM: mean 15.3, SD 8.4 vs hospital 1 UC: mean 5.3, SD 2.4 and hospital 2 UC: mean 8.6, SD 6.1; P <.001). No significant differences were observed regarding cardiologist care time ( P =.27), cardiologist number of consultations ( P =.43), or HF-related readmissions ( P =.47). Conclusions: In this real-world study, the implementation of RPM for patients with HF was associated with a higher nursing workload, with no observed differences in cardiologists’ consultations or patient outcomes. These findings highlight the need for optimization at organizational and technological levels and underline the importance of real-world evaluation of the implementation of innovations.
- 3 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e89187
Open AccessReal-World Impact of Remote Patient Management on Care Consumption and Care Time in Heart Failure: Retrospective Cohort Study
Background: Remote patient management (RPM) is a strategy to track daily health data in patients with heart failure (HF) to enable early detection and treatment of decompensation to prevent hospital readmissions. The implementation of RPM alters standard care and redistributes provider responsibilities. Although randomized controlled trials demonstrate positive clinical outcomes, the impact of implementing RPM on patients’ health care usage, as well as the care time and workload of health care providers in a real-world setting, remains unclear. Objective: The objective of this retrospective study is to explore the effects of implementing RPM for HF on patients’ cardiac care consumption and caregiver workload within a regional care network through the use of real-world data. Methods: Two hospitals in the same regional care network with aligned care pathways for usual care (UC) were compared: one with RPM (hospital 1) and one without (hospital 2). Between June 2021 and July 2022, patients with HF were included from a clinical registry with a 1-year follow-up. Cardiac health care consumption was quantified by the number and duration of consultations (in-person, phone, and RPM) with nurse practitioners specialized in HF care and cardiologists. HF-related readmissions were also collected. Three groups were analyzed: hospital 1 RPM, hospital 1 UC, and hospital 2 UC. Results: A total of 131 patients were included (hospital 1 RPM: 34, hospital 1 UC: 64, hospital 2 UC: 33). Consultation frequency and duration were significantly higher in the hospital 1 RPM cohort compared to the hospital 1 UC and the hospital 2 UC cohorts (frequency: mean 18.5, SD 9.3 vs mean 9.3, SD 6.0 and mean 11.6, SD 6.3; P <.001; duration: mean 233.2, SD 95.2 min vs mean 121.2, SD 47.9 min and mean 113.0, SD 66.0 min; P <.001), mainly due to increased number of consultations of nurse practitioners specialized in HF care (hospital 1 RPM: mean 15.3, SD 8.4 vs hospital 1 UC: mean 5.3, SD 2.4 and hospital 2 UC: mean 8.6, SD 6.1; P <.001). No significant differences were observed regarding cardiologist care time ( P =.27), cardiologist number of consultations ( P =.43), or HF-related readmissions ( P =.47). Conclusions: In this real-world study, the implementation of RPM for patients with HF was associated with a higher nursing workload, with no observed differences in cardiologists’ consultations or patient outcomes. These findings highlight the need for optimization at organizational and technological levels and underline the importance of real-world evaluation of the implementation of innovations.
- Open Access
- 6 July 2026
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 34 (7-8) , 274-282
Clinician-assessed NYHA and EHRA symptom classifications only moderately reflect patient-reported quality of life in heart failure and atrial fibrillation
Background: Clinician-assessed symptoms are expected to agree with patient-perceived symptoms. However, patients may value the impact of symptoms on their health-related quality of life (HRQoL) differently from clinicians. This study aimed to evaluate the relationship between patient-perceived HRQoL and clinician-assessed symptom severity in patients with Heart Failure (HF) and Atrial Fibrillation (AF). Methods: Newly diagnosed HF and AF patients were prospectively included. Information on symptoms and HRQoL was collected at diagnosis and after 12 months during routine HF- and AF-outpatient clinic visits. Symptom severity was assessed by clinicians using the NYHA classification for HF and EHRA score for AF. HRQoL was assessed using the CaReQol-CHF (HF) and AFEQT (AF). Results: Complete baseline and 12-month follow-up information was available for 254 HF patients and 765 AF patients. Moderate correlations were observed between NYHA classification and CaReQoL-CHF at diagnosis and follow-up (Spearman’s ρ: HF social : 0.202 and 0.426, HF physical : 0.317 and 0.421, respectively), and between EHRA score and AFEQT (Spearman’s ρ: −0.363 and −0.305). Clinician-assessed improvement in HF or AF symptoms from diagnosis to 12 months was associated with patient-reported improvement in HRQoL (HF social : F(250.2) = 3.11, p < 0.046; HF physical : F(251.2) = 11.19, p < 0.001; and AF: F(762.2) = 25.86, p < 0.001). When clinicians reported unchanged or worsening symptoms, no significant HRQoL changes were reported by patients. Conclusion: Clinician-assessed symptoms correlate moderately with patient-reported HRQoL, with large inter-individual variation in HRQoL. NYHA and EHRA classifications may not accurately reflect patient-perceived burden of disease over time. Incorporating patient-reported outcomes into routine care may better guide treatment, improve the identification of patients’ needs, and support informed clinical and shared decision-making.
- 6 July 2026
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 34 (7-8) , 274-282
Open AccessClinician-assessed NYHA and EHRA symptom classifications only moderately reflect patient-reported quality of life in heart failure and atrial fibrillation
Background: Clinician-assessed symptoms are expected to agree with patient-perceived symptoms. However, patients may value the impact of symptoms on their health-related quality of life (HRQoL) differently from clinicians. This study aimed to evaluate the relationship between patient-perceived HRQoL and clinician-assessed symptom severity in patients with Heart Failure (HF) and Atrial Fibrillation (AF). Methods: Newly diagnosed HF and AF patients were prospectively included. Information on symptoms and HRQoL was collected at diagnosis and after 12 months during routine HF- and AF-outpatient clinic visits. Symptom severity was assessed by clinicians using the NYHA classification for HF and EHRA score for AF. HRQoL was assessed using the CaReQol-CHF (HF) and AFEQT (AF). Results: Complete baseline and 12-month follow-up information was available for 254 HF patients and 765 AF patients. Moderate correlations were observed between NYHA classification and CaReQoL-CHF at diagnosis and follow-up (Spearman’s ρ: HF social : 0.202 and 0.426, HF physical : 0.317 and 0.421, respectively), and between EHRA score and AFEQT (Spearman’s ρ: −0.363 and −0.305). Clinician-assessed improvement in HF or AF symptoms from diagnosis to 12 months was associated with patient-reported improvement in HRQoL (HF social : F(250.2) = 3.11, p < 0.046; HF physical : F(251.2) = 11.19, p < 0.001; and AF: F(762.2) = 25.86, p < 0.001). When clinicians reported unchanged or worsening symptoms, no significant HRQoL changes were reported by patients. Conclusion: Clinician-assessed symptoms correlate moderately with patient-reported HRQoL, with large inter-individual variation in HRQoL. NYHA and EHRA classifications may not accurately reflect patient-perceived burden of disease over time. Incorporating patient-reported outcomes into routine care may better guide treatment, improve the identification of patients’ needs, and support informed clinical and shared decision-making.
- Open Access
- 9 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Real-world Evaluation of the Impact of Remote Patient Management in Heart Failure on Care Consumption and Care Time (Preprint)
BACKGROUND Remote Patient Management (RPM) is a strategy to track daily health data in patients with heart failure (HF) to enable early detection and treatment of decompensation to prevent hospital readmissions. Implementation of RPM alters standard care and redistributes provider responsibilities. Although randomized controlled trials demonstrate positive clinical outcomes, the impact of implementing remote patient monitoring on patients’ healthcare utilization, as well as the care time and workload of healthcare providers in a real-world setting, remains unclear. OBJECTIVE The goal of this retrospective study is to evaluate the effects of implementing remote patient monitoring for heart failure on patient care consumption and caregiver workload within a regional care network. METHODS Two hospitals in the same regional care network with aligned care pathways for usual care were compared: one with remote patient monitoring (Hospital 1) and one without (Hospital 2). Between June 2021 and July 2022, HF patients were included from a clinical registry with one-year follow-up. Cardiac healthcare consumption was quantified by the number and duration of consultations (in-person, phone, RPM) with HF-nurses and cardiologists. HF-related readmissions were also collected. Three groups were analyzed: Hospital 1 Usual Care (UC)+RPM, Hospital 1 UC, and Hospital 2 UC. RESULTS 131 patients were included (Hospital 1 UC+RPM: 34, Hospital 1 UC: 64, Hospital 2 UC: 33). Consultation frequency and duration were significantly higher in the UC+RPM group (p < 0.001), mainly due to increased HF-nurse consultations (p < 0.001). No significant differences were observed regarding cardiologist care time, cardiologist number of consultations or HF-related readmissions. CONCLUSIONS In this real-world study, implementation of RPM in patients with HF increased nurses' workload without benefit on cardiologists’ consultations or patient outcomes. These findings highlight the need for optimization at organizational and technological levels and underline the importance of real-world evaluation of implementations of innovations.
- 9 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessReal-world Evaluation of the Impact of Remote Patient Management in Heart Failure on Care Consumption and Care Time (Preprint)
BACKGROUND Remote Patient Management (RPM) is a strategy to track daily health data in patients with heart failure (HF) to enable early detection and treatment of decompensation to prevent hospital readmissions. Implementation of RPM alters standard care and redistributes provider responsibilities. Although randomized controlled trials demonstrate positive clinical outcomes, the impact of implementing remote patient monitoring on patients’ healthcare utilization, as well as the care time and workload of healthcare providers in a real-world setting, remains unclear. OBJECTIVE The goal of this retrospective study is to evaluate the effects of implementing remote patient monitoring for heart failure on patient care consumption and caregiver workload within a regional care network. METHODS Two hospitals in the same regional care network with aligned care pathways for usual care were compared: one with remote patient monitoring (Hospital 1) and one without (Hospital 2). Between June 2021 and July 2022, HF patients were included from a clinical registry with one-year follow-up. Cardiac healthcare consumption was quantified by the number and duration of consultations (in-person, phone, RPM) with HF-nurses and cardiologists. HF-related readmissions were also collected. Three groups were analyzed: Hospital 1 Usual Care (UC)+RPM, Hospital 1 UC, and Hospital 2 UC. RESULTS 131 patients were included (Hospital 1 UC+RPM: 34, Hospital 1 UC: 64, Hospital 2 UC: 33). Consultation frequency and duration were significantly higher in the UC+RPM group (p < 0.001), mainly due to increased HF-nurse consultations (p < 0.001). No significant differences were observed regarding cardiologist care time, cardiologist number of consultations or HF-related readmissions. CONCLUSIONS In this real-world study, implementation of RPM in patients with HF increased nurses' workload without benefit on cardiologists’ consultations or patient outcomes. These findings highlight the need for optimization at organizational and technological levels and underline the importance of real-world evaluation of implementations of innovations.
- Open Access
- 5 April 2023
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 21 (1) , 1-10
The prognostic value of quality of life in atrial fibrillation on patient value
In this study, the prognostic value of AF-related quality of life (AFEQT) at baseline on Major Adverse Cardiovascular Events (MACE) and improvement of perceived symptoms (EHRA) was assessed. Furthermore, the relationship between QoL and AF-related hospitalizations was assessed. A cohort of AF-patients diagnosed between November 2014 and October 2019 in four hospitals embedded within the Netherlands Heart Network were prospectively followed for 12 months. MACE was defined as stroke, myocardial infarction, heart failure and/or mortality. Subsequently, MACE, EHRA score improvement and AF-related hospitalizations between baseline and 12 months of follow-up were recorded. In total, 970 AF-patients were available for analysis. In analyses with patients with complete information on the confounder subset 36/687 (5.2%) AF-patients developed MACE, 190/432 (44.0%) improved in EHRA score and 189/510(37.1%) were hospitalized during 12 months of follow-up. Patients with a low AFEQT score at baseline more often developed MACE (OR(95%CI): 2.42(1.16–5.06)), more often improved in EHRA score (OR(95%CI): 4.55(2.45–8.44) and were more often hospitalized (OR(95%CI): 4.04(2.22–7.01)) during 12 months post diagnosis, compared to patients with a high AFEQT score at baseline. AF-patients with a lower quality of life at diagnosis more often develop MACE, more often improve on their symptoms and also were more often hospitalized, compared to AF-patients with a higher quality of life. This study highlights that the integration of patient-reported outcomes, such as quality of life, has the potential to be used as a prognostic indicator of the expected disease course for AF.
- 5 April 2023
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 21 (1) , 1-10
Open AccessThe prognostic value of quality of life in atrial fibrillation on patient value
In this study, the prognostic value of AF-related quality of life (AFEQT) at baseline on Major Adverse Cardiovascular Events (MACE) and improvement of perceived symptoms (EHRA) was assessed. Furthermore, the relationship between QoL and AF-related hospitalizations was assessed. A cohort of AF-patients diagnosed between November 2014 and October 2019 in four hospitals embedded within the Netherlands Heart Network were prospectively followed for 12 months. MACE was defined as stroke, myocardial infarction, heart failure and/or mortality. Subsequently, MACE, EHRA score improvement and AF-related hospitalizations between baseline and 12 months of follow-up were recorded. In total, 970 AF-patients were available for analysis. In analyses with patients with complete information on the confounder subset 36/687 (5.2%) AF-patients developed MACE, 190/432 (44.0%) improved in EHRA score and 189/510(37.1%) were hospitalized during 12 months of follow-up. Patients with a low AFEQT score at baseline more often developed MACE (OR(95%CI): 2.42(1.16–5.06)), more often improved in EHRA score (OR(95%CI): 4.55(2.45–8.44) and were more often hospitalized (OR(95%CI): 4.04(2.22–7.01)) during 12 months post diagnosis, compared to patients with a high AFEQT score at baseline. AF-patients with a lower quality of life at diagnosis more often develop MACE, more often improve on their symptoms and also were more often hospitalized, compared to AF-patients with a higher quality of life. This study highlights that the integration of patient-reported outcomes, such as quality of life, has the potential to be used as a prognostic indicator of the expected disease course for AF.
- Open Access
- 3 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 3 (4) , 570-577
Regional implementation of atrial fibrillation screening: benefits and pitfalls
Aims: Despite general awareness that screening for atrial fibrillation (AF) could reduce health hazards, large-scale implementation is lagging behind technological developments. As the successful implementation of a screening programme remains challenging, this study aims to identify facilitating and inhibiting factors from healthcare providers’ perspectives.Methods and results: A mixed-methods approach was used to gather data among practice nurses in primary care in the southern region of the Netherlands to evaluate the implementation of an ongoing single-lead electrocardiogram (ECG)-based AF screening programme. Potential facilitating and inhibiting factors were evaluated using online questionnaires (N = 74/75%) and 14 (of 24) semi-structured in-depth interviews (58.3%). All analyses were performed using SPSS 26.0. In total, 16 682 screenings were performed on an eligible population of 64 000, and 100 new AF cases were detected. Facilitating factors included ‘receiving clear instructions’ (mean ± SD; 4.12 ± 1.05), ‘easy use of the ECG-based device’ (4.58 ± 0.68), and ‘patient satisfaction’ (4.22 ± 0.65). Inhibiting factors were ‘time availability’ (3.20 ± 1.10), ‘insufficient feedback to the practice nurse’ (2.15 ± 0.89), ‘absence of coordination’ (54%), and the ‘lack of fitting policy’ (32%).Conclusion: Large-scale regional implementation of an AF screening programme in primary care resulted in a low participation of all eligible patients. Based on the perceived barriers by healthcare providers, future AF screening programmes should create preconditions to fit the intervention into daily routines, appointing an overall project lead and a General Practitioner (GP) as a coordinator within every GP practice.
- 3 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 3 (4) , 570-577
Open AccessRegional implementation of atrial fibrillation screening: benefits and pitfalls
Aims: Despite general awareness that screening for atrial fibrillation (AF) could reduce health hazards, large-scale implementation is lagging behind technological developments. As the successful implementation of a screening programme remains challenging, this study aims to identify facilitating and inhibiting factors from healthcare providers’ perspectives.Methods and results: A mixed-methods approach was used to gather data among practice nurses in primary care in the southern region of the Netherlands to evaluate the implementation of an ongoing single-lead electrocardiogram (ECG)-based AF screening programme. Potential facilitating and inhibiting factors were evaluated using online questionnaires (N = 74/75%) and 14 (of 24) semi-structured in-depth interviews (58.3%). All analyses were performed using SPSS 26.0. In total, 16 682 screenings were performed on an eligible population of 64 000, and 100 new AF cases were detected. Facilitating factors included ‘receiving clear instructions’ (mean ± SD; 4.12 ± 1.05), ‘easy use of the ECG-based device’ (4.58 ± 0.68), and ‘patient satisfaction’ (4.22 ± 0.65). Inhibiting factors were ‘time availability’ (3.20 ± 1.10), ‘insufficient feedback to the practice nurse’ (2.15 ± 0.89), ‘absence of coordination’ (54%), and the ‘lack of fitting policy’ (32%).Conclusion: Large-scale regional implementation of an AF screening programme in primary care resulted in a low participation of all eligible patients. Based on the perceived barriers by healthcare providers, future AF screening programmes should create preconditions to fit the intervention into daily routines, appointing an overall project lead and a General Practitioner (GP) as a coordinator within every GP practice.
- Open Access
- 20 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma
In this study, we investigate the influence of the seven genes (VHL, PBRM1, SETD2, BAP1, KDM5C, MTORandTP53) most frequently mutated in clear cell renal cell cancer (ccRCC) on cancer-specific survival (CSS) in the prospective Netherlands Cohort Study on diet and cancer. DNA isolated from routinely archived formalin-fixed paraffin-embedded tumour blocks from 252 incident ccRCC cases was available for targeted next generation sequencing. Based on the sequencing quality and the completeness of information on clinical characteristics and follow-up, we could use 110 cases for survival analysis. The association with CSS for each mutated gene in these cases was tested using multivariable Cox proportional hazards models to estimate hazards ratios (HR) and confidence intervals (CIs), and we observed mutations in one or more of the seven genes in 64 out of 110 cases (58%). In the multivariable-adjusted analyses, mutations inVHLandPBRM1were associated with better CSS (HRs (95% CI) 0.34 (0.13‒0.89) and 0.17 (0.04–0.66), respectively), although these results were not statistically significant after multiple testing correction. No association was observed for the other five genes, which may be attributable to limited power.
- 20 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Open AccessEvaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma
In this study, we investigate the influence of the seven genes (VHL, PBRM1, SETD2, BAP1, KDM5C, MTORandTP53) most frequently mutated in clear cell renal cell cancer (ccRCC) on cancer-specific survival (CSS) in the prospective Netherlands Cohort Study on diet and cancer. DNA isolated from routinely archived formalin-fixed paraffin-embedded tumour blocks from 252 incident ccRCC cases was available for targeted next generation sequencing. Based on the sequencing quality and the completeness of information on clinical characteristics and follow-up, we could use 110 cases for survival analysis. The association with CSS for each mutated gene in these cases was tested using multivariable Cox proportional hazards models to estimate hazards ratios (HR) and confidence intervals (CIs), and we observed mutations in one or more of the seven genes in 64 out of 110 cases (58%). In the multivariable-adjusted analyses, mutations inVHLandPBRM1were associated with better CSS (HRs (95% CI) 0.34 (0.13‒0.89) and 0.17 (0.04–0.66), respectively), although these results were not statistically significant after multiple testing correction. No association was observed for the other five genes, which may be attributable to limited power.
- Open Access
- 10 January 2022
- Published by Wiley in Journal of Arrhythmia
- Vol. 38 (1) , 50-57
Age‐dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillation
Background: In this study, the relationship between AF‐related quality of life (AFEQT) at baseline in AF‐patients and the improvement on perceived symptoms and general state of health (EHRA, European Heart Rhythm Association score) at 12 months was assessed across predefined age categories.Methods: Between November 2014 and October 2019 patients diagnosed with AF de novo in four hospitals embedded within the Netherlands Heart Network were prospectively followed for 12 months. These AF‐patients were categorized into quartiles based on their AFEQT score at diagnosis and EHRA score was measured at diagnosis and 12 months of follow‐up. Stratified analyses were performed using age categories (<65 vs. ≥65 years; <75 vs. ≥75 years).Results: In total, 203/483 (42.0%) AF‐patients improved in EHRA score after 12 months of follow‐up. AF‐patients in the lowest AFEQT quartile were more likely to improve, compared to patients in the highest AFEQT quartile (OR [95%CI]:4.73 [2.63–8.50]). Furthermore, patients ≥65 years and patients <75 years at diagnosis with lower AFEQT scores at baseline were most likely to improve in EHRA score after 12 months, compared to similarly aged patients with higher AFEQT scores at baseline.Conclusion: The present study indicates that AF‐patients with a lower quality of life at diagnosis were most likely to improve their EHRA score after 12 months. This effect was most prominent in patients ≥65 years of age and patients 65 and ≥75 years, respectively. Future research should focus on further defining characteristics of these age groups to enable the implementation of age‐tailored treatment.
- 10 January 2022
- Published by Wiley in Journal of Arrhythmia
- Vol. 38 (1) , 50-57
Open AccessAge‐dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillation
Background: In this study, the relationship between AF‐related quality of life (AFEQT) at baseline in AF‐patients and the improvement on perceived symptoms and general state of health (EHRA, European Heart Rhythm Association score) at 12 months was assessed across predefined age categories.Methods: Between November 2014 and October 2019 patients diagnosed with AF de novo in four hospitals embedded within the Netherlands Heart Network were prospectively followed for 12 months. These AF‐patients were categorized into quartiles based on their AFEQT score at diagnosis and EHRA score was measured at diagnosis and 12 months of follow‐up. Stratified analyses were performed using age categories (<65 vs. ≥65 years; <75 vs. ≥75 years).Results: In total, 203/483 (42.0%) AF‐patients improved in EHRA score after 12 months of follow‐up. AF‐patients in the lowest AFEQT quartile were more likely to improve, compared to patients in the highest AFEQT quartile (OR [95%CI]:4.73 [2.63–8.50]). Furthermore, patients ≥65 years and patients <75 years at diagnosis with lower AFEQT scores at baseline were most likely to improve in EHRA score after 12 months, compared to similarly aged patients with higher AFEQT scores at baseline.Conclusion: The present study indicates that AF‐patients with a lower quality of life at diagnosis were most likely to improve their EHRA score after 12 months. This effect was most prominent in patients ≥65 years of age and patients 65 and ≥75 years, respectively. Future research should focus on further defining characteristics of these age groups to enable the implementation of age‐tailored treatment.
- 11 February 2021
- Published by Maastricht University
Renal cell cancer
- Open Access
- 7 July 2020
- Published by Wiley in International Journal of Cancer
- Vol. 148 (1) , 67-76
Etiologic heterogeneity of clear‐cell and papillary renal cell carcinoma in the Netherlands Cohort Study
At present, mostly case‐control and retrospective studies have investigated the association between etiologic risk factors and the development of histologic subtypes of renal cell carcinoma (RCC). Therefore, we assessed the heterogeneity between body mass index (BMI), cigarette smoking, alcohol consumption and hypertension across clear‐cell RCC (ccRCC) and papillary RCC (pRCC) risk in the prospective Netherlands Cohort Study on diet and cancer. In 1986, 120 852 participants aged 55 to 69 completed a self‐administered questionnaire on diet and other risk factors for cancer. Participants were followed up for cancer through record linkage. Tumor histology was assessed through centralized revision by two experienced uropathologists. After 20.3 years of follow‐up, 384 histologically verified RCC cases, including 315 ccRCC and 46 pRCC cases and 4144 subcohort members were eligible for case‐cohort analysis. Hazard ratios and 95% confidence intervals were estimated by multivariable‐adjusted proportional hazards models. Overall, BMI was associated positively with ccRCC risk, but inversely with pRCC risk. Cigarette smoking was associated with an increased ccRCC, but a decreased pRCC risk. Alcohol consumption was inversely associated with both ccRCC and pRCC risk. Hypertension was associated with an increased risk of both ccRCC and pRCC. Statistically significant etiologic heterogeneity was observed for BMI, BMI change since age 20, and smoking duration in current smokers across ccRCC and pRCC risk. In conclusion, we observed potential heterogeneity for BMI, BMI change and smoking duration across ccRCC and pRCC risk.
- 7 July 2020
- Published by Wiley in International Journal of Cancer
- Vol. 148 (1) , 67-76
Open AccessEtiologic heterogeneity of clear‐cell and papillary renal cell carcinoma in the Netherlands Cohort Study
At present, mostly case‐control and retrospective studies have investigated the association between etiologic risk factors and the development of histologic subtypes of renal cell carcinoma (RCC). Therefore, we assessed the heterogeneity between body mass index (BMI), cigarette smoking, alcohol consumption and hypertension across clear‐cell RCC (ccRCC) and papillary RCC (pRCC) risk in the prospective Netherlands Cohort Study on diet and cancer. In 1986, 120 852 participants aged 55 to 69 completed a self‐administered questionnaire on diet and other risk factors for cancer. Participants were followed up for cancer through record linkage. Tumor histology was assessed through centralized revision by two experienced uropathologists. After 20.3 years of follow‐up, 384 histologically verified RCC cases, including 315 ccRCC and 46 pRCC cases and 4144 subcohort members were eligible for case‐cohort analysis. Hazard ratios and 95% confidence intervals were estimated by multivariable‐adjusted proportional hazards models. Overall, BMI was associated positively with ccRCC risk, but inversely with pRCC risk. Cigarette smoking was associated with an increased ccRCC, but a decreased pRCC risk. Alcohol consumption was inversely associated with both ccRCC and pRCC risk. Hypertension was associated with an increased risk of both ccRCC and pRCC. Statistically significant etiologic heterogeneity was observed for BMI, BMI change since age 20, and smoking duration in current smokers across ccRCC and pRCC risk. In conclusion, we observed potential heterogeneity for BMI, BMI change and smoking duration across ccRCC and pRCC risk.
- Open Access
- 10 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer
We investigated the relationship between germline single nucleotide polymorphisms (SNPs) in Von Hippel-Lindau (VHL) and Hypoxia-inducible factor 1-alpha (HIF1A), and their gene-environment and gene-gene interactions, and clear-cell RCC (ccRCC) risk. Furthermore, we assessed the relationship between VHL SNPs and VHL promoter methylation. Three VHL polymorphisms and one HIF1A polymorphism were genotyped in the Netherlands Cohort Study. In 1986, 120,852 participants aged 55–69 completed a self-administered questionnaire on diet and lifestyle and toenail clippings were collected. Toenail DNA was genotyped using the Sequenom MassARRAY platform. After 20.3 years, 3004 subcohort members and 406 RCC cases, of which 263 ccRCC cases, were eligible for multivariate case-cohort analyses. VHL_rs779805 was associated with RCC (Hazard Ratio (HR) 1.53; 95% Confidence Interval (CI) 1.07–2.17) and ccRCC risk (HR 1.88; 95% CI 1.25–2.81). No associations were found for other SNPs. Potential gene-environment interactions were found between alcohol consumption and selected SNPs. However, none remained statistically significant after multiple comparison correction. No gene-gene interactions were observed between VHL and HIF1A. VHL promoter methylation was not associated with VHL SNPs. VHL SNPs may increase (cc)RCC susceptibility. No associations were found between gene-environment and gene-gene interactions and (cc)RCC risk and between VHL promoter methylation and VHL SNPs.
- 10 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Open AccessGermline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer
We investigated the relationship between germline single nucleotide polymorphisms (SNPs) in Von Hippel-Lindau (VHL) and Hypoxia-inducible factor 1-alpha (HIF1A), and their gene-environment and gene-gene interactions, and clear-cell RCC (ccRCC) risk. Furthermore, we assessed the relationship between VHL SNPs and VHL promoter methylation. Three VHL polymorphisms and one HIF1A polymorphism were genotyped in the Netherlands Cohort Study. In 1986, 120,852 participants aged 55–69 completed a self-administered questionnaire on diet and lifestyle and toenail clippings were collected. Toenail DNA was genotyped using the Sequenom MassARRAY platform. After 20.3 years, 3004 subcohort members and 406 RCC cases, of which 263 ccRCC cases, were eligible for multivariate case-cohort analyses. VHL_rs779805 was associated with RCC (Hazard Ratio (HR) 1.53; 95% Confidence Interval (CI) 1.07–2.17) and ccRCC risk (HR 1.88; 95% CI 1.25–2.81). No associations were found for other SNPs. Potential gene-environment interactions were found between alcohol consumption and selected SNPs. However, none remained statistically significant after multiple comparison correction. No gene-gene interactions were observed between VHL and HIF1A. VHL promoter methylation was not associated with VHL SNPs. VHL SNPs may increase (cc)RCC susceptibility. No associations were found between gene-environment and gene-gene interactions and (cc)RCC risk and between VHL promoter methylation and VHL SNPs.